Commonwealth of Australia Explanatory Memoranda

[Index] [Search] [Download] [Bill] [Help]


NATIONAL HEALTH AMENDMENT (PHARMACEUTICAL AND OTHER BENEFITS-COST RECOVERY) BILL 2009




                                    2008





               THE PARLIAMENT OF THE COMMONWEALTH OF AUSTRALIA



                          HOUSE OF REPRESENTATIVES










     NATIONAL HEALTH AMENDMENT (PHARMACEUTICAL AND OTHER BENEFITS - COST
                             RECOVERY) BILL 2008





                           EXPLANATORY MEMORANDUM














       (Circulated by authority of the Minister for Health and Ageing,
                       the Honourable Nicola Roxon MP)


     NATIONAL HEALTH AMENDMENT (PHARMACEUTICAL AND OTHER BENEFITS - COST
                             RECOVERY) BILL 2008


OUTLINE


The purpose of the Bill is to amend the National Health Act 1953 (the Act)
to enable regulations to be made with respect to services provided by the
Commonwealth associated with the exercise of powers by the Minister for the
Pharmaceutical Benefits Scheme (PBS) (under Part VII of the Act) and the
National Immunisation Program (NIP) (under section 9B of the Act).

While the Bill provides for a commencement date of 1 July 2008, the cost
recovery regime cannot commence until the subordinate regulations are made
by the Governor-General.  The commencement date for the charging of fees
will be contained in the regulations which are subject to parliamentary
scrutiny and disallowance.

The Bill provides that the regulations may include prescription of fees
payable in relation to those services provided by the Commonwealth such as
the making of declarations, determinations, agreements and arrangements.

Services provided by the Commonwealth in relation to the exercise of those
powers by the Minister include the performance of functions by the
Pharmaceutical Benefits Advisory Committee (PBAC) and its subcommittees,
the Pharmaceutical Benefits Pricing Authority, and related services
performed by Departmental officers, contractors and sub-contractors.

The regulations will provide for recovery of relevant fees from persons
(including pharmaceutical companies) who make an application or submission
for services associated with new, and changes to existing, listings on the
PBS or with vaccines designated under section 9B of the Act.

The regulations will set out the fees that are payable for the relevant
services provided by the Commonwealth and designate the time and manner of
payment, and consequences for failure to pay the fee.  The Bill empowers
the Minister to refuse to exercise powers under section 9B or Part VII of
the Act until a fee is paid.


FINANCIAL IMPACT STATEMENT


Revenue from fees representing the cost recovery of the relevant services
will depend on the number and type of submissions brought to the PBAC for
consideration.  Fees are expected to be around $14 million per year in the
first full financial year of operations. However, revenue estimates cannot
be finalised until a commencement date is determined.


     NATIONAL HEALTH AMENDMENT (PHARMACEUTICAL AND OTHER BENEFITS - COST
                             RECOVERY) BILL 2008



NOTES ON CLAUSES


Clause 1: Short title
This clause is a formal provision specifying the short title of the Bill.

Clause 2: Commencement
Sections 1 to 3 will commence on the day on which the Bill receives Royal
Assent.  Schedule 1 will commence on 1 July 2008.  Submissions received by
PBAC following the making of regulations under the amended Act will be
subject to the prescribed cost recovery arrangement.

Clause 3: Schedule
This clause provides that each Act specified in a Schedule to the Bill is
amended as specified, and any other item has effect according to its terms.


Schedule 1 - Cost recovery
Schedule 1 contains the amendment to the Act which gives effect to the
proposed cost recovery arrangements.

Item 1
This item inserts a new Division 4C after Division 4B of Part VII.  It
comprises three Subdivisions - A, B and C.

DIVISION 4C - COST RECOVERY

Subdivision A - Preliminary

Section 99YB: What this Division is about
This section explains that:
    . Division 4C enables the charging of fees for certain services provided
      by the Commonwealth.  The fees may only be charged where the service
      provided by the Commonwealth relates to the exercise of certain powers
      by the Minister under the Act;
    . Subdivision B provides for the making of regulations to prescribe fees
      payable for those services and some other matters relating to payment
      of the fees, including some consequences of failure to pay the fees.
      It is intended that the fees be recovered from persons (including
      pharmaceutical companies) who make an application or submissions for
      services associated with new, and changes to existing, listings on the
      PBS or with vaccines designated under section 9B of the Act; and
    . Subdivision C provides further powers to the Minister if fees are not
      paid.

Subdivision B - Payment of fees etc. for certain services

Section 99YBA: Payment of fees etc. for certain services
Subsection 99YBA(1) enables the making of regulations concerning the
provision of services by the Commonwealth in relation to the exercise of
powers by the Minister under section 9B or Part VII of the Act.
The powers that may be exercised by the Minister under Part VII of the Act
(which provides for the PBS include making various declarations,
determinations, agreements and arrangements in relation to drugs and
medicinal preparations and special pharmaceutical products).  The powers
that may be exercised by the Minister under section 9B of the Act include
determining that a specified vaccine is a "designated vaccine", and that it
may be provided in specified circumstances (including for the NIP).

Services provided by the Commonwealth in relation to the exercise of those
powers by the Minister include performance by the PBAC, and its
subcommittees, of its functions under the Act.  Those functions include
making recommendations and giving advice associated with new, and changes
to existing, listings on the PBS and with vaccines designated on the NIP.

Other relevant services provided by the Commonwealth include evaluation and
pricing activities by the Pharmaceutical Benefits Pricing Authority,
departmental officers and contractors associated with pharmaceutical
benefits and special pharmaceutical products and the designation of
vaccines.

Subsection 99YBA(2) makes provision for regulations about some specific
matters without limiting the generality of the regulation-making power
provided in subsection 99YBA(1).  It states that the regulations may make
provision for the making of applications for the relevant services provided
by the Commonwealth, the prescribing of fees for those services, time and
manner of payment of the prescribed fees, penalties for late payment, fee
waivers and exemptions, refusal of services until fees are paid, and review
of decisions made under the regulations.

Subsection 99YBA(3) provides that a prescribed fee must not be such as to
amount to taxation.

Subsections 99YBA(4) and (5) provide that a prescribed fee is payable to,
and may be recovered as a debt due to, the Commonwealth.

Subdivision C - Consequences if fees not paid

Section 99YBB: Minister may refuse to exercise certain powers if prescribed
fees not paid
This section provides that the Minister may refuse to exercise certain
powers under section 9B or Part VII if fees are not paid.  If a person has
not paid a fee prescribed under paragraph 99YBA(2)(b), the Minister may
refuse to exercise a power in relation to any service that is referred to
in subsection 99YBA(1) that the person has applied for.  The provision
makes it clear that existing powers of the Minister under section 9B or
Part VII of the Act are not affected by the operation of this new section.

Subsection 99YBB(2) confirms for the assistance of readers that any refusal
to exercise a power referred to in subsection 99YBB(1) is not a legislative
instrument.

 


[Index] [Search] [Download] [Bill] [Help]